News and Trends 4 Feb 2025Akribion Therapeutics emerges from stealth with programmable cell depletion RNA technology Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach February 4, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 3 Feb 2025The biggest biotech funding rounds in January 2025 The companies Immunovant, Verdiva Bio, and Akero Therapeutics bagged the biggest biotech funding rounds overall in January 2025. February 3, 2025 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 31 Jan 2025U.K. biotech defies the odds, raising £3.5B in 2024 The U.K. biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report. January 31, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 31 Jan 2025Can tumor activated therapy kill solid tumors? Solid tumors are a big challenge. However, a new approach might provide the answer – tumor-activated Therapy. We discuss this with Seekyo Therapeutics’ CEO, Oury Chetboun January 31, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Best in Biotech 30 Jan 2025Seven genome sequencing companies to look out for There are a number of genomics startups that have sprouted up to strengthen their sequencing technologies to aid in disease prevention and treatment. January 30, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 29 Jan 2025Pancreatic cancer: Oncolytics Biotech, Candel, and CytomX bring promising therapies to the clinic Discover the treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to treat. January 29, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jan 2025ITM-11 succeeds in phase 3: The first big win for radiopharma? Discover ITM and its cancer candidate ITM-11, as it brings one of the first big wins the radiopharmaceutical sector awaits. January 28, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 27 Jan 2025Top 19 most-performing biotech stocks of 2024 Discover the top-performing biotech stocks in 2024 – from oncology to psychedelics some companies showed remarkable results. January 27, 2025 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 24 Jan 2025Why are there only 20 cell and gene therapies in Europe? There are 20 cell and gene therapies on Europe’s market versus 43 in the U.S. Find out more about this ecosystem. January 24, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 24 Jan 2025J.P. Morgan Annual Healthcare Conference 2025: trends and highlights you may have missed With Orca Bio’s CEO, Ivan Dimov,, we take a look at some of the highlights from the 43rd Annual J.P. Morgan Healthcare Conference January 24, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 23 Jan 2025mRNA, RNAi, circRNA, ASOs: A comparative guide to RNA therapeutics In this review of RNA therapies, we paint an overview of what’s going on in a field that could address a number of diseases. January 23, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Jan 2025Curing ALS? Sixteen companies developing new treatments in 2025 Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in 2025. January 22, 2025 - 18 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email